Researchers have developed an infrared laser-driven mass spectrometry imaging (MSI) platform capable of routine 3 μm-pixel resolution, according to a report published in Nature.
The system captures molecular maps of metabolites and phospholipids in fresh-frozen and formalin-fixed tissue samples without requiring traditional matrix preparation.
The platform utilizes a custom 2.94 μm light source to deliver picosecond pulses at high repetition rates. By maintaining low-fluence laser ablation, the system produces well-confined features with diameters ranging from 5 μm to 10 μm, Nature reported. This configuration allows for oversampled images that preserve sub-cellular morphology, correlating directly with histological and fluorescence data.
Previous work presented at the Optical Interactions with Tissue and Cells XXXIV conference in March 2023 described a similar laser desorption-based platform. That system, which utilized an optical parametric amplifier to generate 200 nJ pulses, achieved a single-cell level resolution of 10 μm. The current Nature findings extend this capability, refining the operational regime to support high-fidelity molecular mapping in a fully ambient, clinically compatible format.
| Parameter | Capability |
|---|---|
| Ablation feature size | 5 μm to 10 μm |
| Routine pixel size | 3 μm |
| Pulse duration | ~100 ps |
| Maximum repetition rate | 500 kHz |
The integration of the laser ablation plume into a rapid evaporative ionisation mass spectrometry (REIMS) interface enables multiplexed ion detection. This setup allows researchers to transition from fresh-frozen tissue sections to biopsy samples without additional preparation steps, as noted in the Nature findings.
How does this laser approach improve image fidelity?
The system uses high-repetition-rate, low-fluence picosecond pulses to minimize tissue damage. This gentle ablation process maintains the molecular integrity of the sample, allowing for higher resolution without the signal loss typically associated with reducing the sampling area.
Does this method require chemical matrices?
No, the system is matrix-free.
By coupling the laser ablation directly to a REIMS interface, the platform avoids the chemical preparation steps that can often complicate traditional mass spectrometry imaging workflows.
What types of samples can be analyzed?
The platform is compatible with both fresh-frozen tissue sections and formalin-fixed, paraffin-embedded biopsy samples. These samples can be imaged at a 3 μm-pixel size, enabling molecular mapping that correlates with standard histological features.